Parvoviruses and bone marrow failure

Stem Cells

Volumn 14, Issue 2, 1996, Pages 151-163

  Brown, Kevin E ^a,b   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bone marrow diseases; Diagnosis; Hematopoiesis; Parvovirus B19 infection; Red cell aplasia; Treatment

Indexed keywords

CELL RECEPTOR; GLOBOSIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VACCINE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; BONE MARROW DEPRESSION; CYTOTOXICITY; ERYTHEMA INFECTIOSUM; ERYTHROCYTE APLASIA; ERYTHROID PRECURSOR CELL; HEMATOPOIESIS; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INOCULATION; INTRAUTERINE INFECTION; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; ORGAN TRANSPLANTATION; PARVOVIRUS; REVIEW; THROMBOCYTOPENIA; VIRUS TRANSCRIPTION;

DNA VIRUSES; HYDROPS; PARVOVIRUS;

EID: 0029922256     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140151     Document Type: Review

References (95)

1. Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994;6:1-31.
2. Kajigaya S, Fujii H, Field A et al. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci USA 1991;88:4646-4650.
3. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988;25:151-153.
4. Koch WC, Adler SP. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 1989;8:83-87.
5. Bell LM, Naides SJ, Stoffman P et al. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989;321:485-491.
6. Seng C, Watkins P, Morse D et al. Parvovirus B19 outbreak on an adult ward. Epidemiol Infect 1994;113:345-353.
7. Williams MD, Cohen BJ, Beddall AC et al. Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang 1990;58:177-181.
8. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-117.
9. Landsteiner K, Levine P. Further observations on individual differences of human blood. Proc Soc Exp Biol Med 1927;24:941-942.
10. Issitt PD. The P blood group system. In: Issitt PD, ed. Applied Blood Group Serology. 3rd ed. Miami, FL: Montaomery Scientific Publications, 1985:203-218.
11. Brown KE. Hibbs JR, Gallinella G et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192-1196.
12. Liu JM, Green SW, Shimada T et al. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol 1992;66:4686-4692.
13. Srivastava A, Bruno E, Briddell R et al. Parvovirus B19-induced perturbation of human megakary-ocytopoiesis in vitro Blood 1990;76:1997-2004
14. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986;233:883-886.
15. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 1988;62:3059-3063.
16. Serke S, Schwarz TF. Baurmann H et al. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry. flow-cytometry and DNA-hybridization. Br J Haematol 1991;79:6-13.
17. Yaegashi N, Shiraishi H. Takeshita T et al. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 1989;63:2422-2426.
18. Brown KE, Mori J, Cohen BJ et al. In vitro propagation of parvovirus B19 in primary foetal liver culture. J Gen Virol 1991;72:741-745.
19. Shimomura S, Komatsu N. Frickhofen N et al. First continuous propagation of B19 parvovirus in a cell line. Blood 1992;79:18-24.
20. Munshi NC, Zhou S, Woody MJ et al. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. J Virol 1993;67:562-566.
21. Takahashi T, Ozawa K. Takahashi K et al. DNA replication of parvovirus B 19 in a human erythroid leukemia cell line (JK-1) in vitro. Arch Virol 1993;131:201-208.
22. Takahashi T, Ozawa K, Takahashi K et al. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 1990;75:603-610.
23. Van Horn DK, Mortimer PP, Young N et al. Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia. Am J Pediatr Hematol Oncol 1986;8:235-239.
24. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 1987;70:384-391.
25. Young N, Harrison M, Moore J et al. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest 1984;74:2024-2032.
26. Morey AL, Ferguson DJ, Fleming KA. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis. J Pathol 1993;169:213-220.
27. Ozawa K, Ayub J, Kajigaya S et al. The gene encoding the nonstructural protein of B 19 (human) parvovirus may be lethal in transfected cells. J Virol 1988;62:2884-2889.
28. Jindal HK, Yong CB, Wilson GM et al. Mutations in the NTP-binding motif of minute virus of mice (MVM) NS-1 protein uncouple ATPase and DNA helicase functions. J Biol Chem 1994;269:3283-3289.
29. Im DS, Muzyczka N. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 1993;61:447-457.
30. Li X, Rhode SL. Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions for viral DNA replication, late promoter transactivation, and cytotoxicity. J Virol 1990;64:4654-4660.
31. Momoeda M, Wong S, Kawase M et al. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol 1994;68:8443-8446.
32. Anderson MJ, Higgins PG. Davis LR et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-265.
33. Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) 1983;91:113-130.
34. Saikawa T, Anderson S, Momoeda M et al. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993;67.3004-3009.
35. Kurtzman GJ, Cohen BJ, Field AM et al. Immune response to B19 parvovirus and an antibody detect in persistent viral infection. J Clin Invest 1989;84:1114-1123.
36. Owren PA. Congenital hemolytic jaundice: the pathogenesis of the "hemolytic crisis". Blood 1948;3:231-248.
37. Pattison JR, Jones SE. Hodgson J et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981:i:664-665.
38. Serjeant GR, Topley JM, Mason K et al. Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent. Lancet 1981:ii:595-597.
39. Kelleher JF, Luban NL, Mortimer PP et al. Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr 1983;102:720-722.
40. Brownell AI, McSwiggan DA, Cubitt WD et al. Aplastic and hypoplastic episodes in sickle cell disease and thalassaemia intermedia. J Clin Pathol 1986;39:121-124.
41. Lowenthal EA, Prchal JT. Parvovirus B19 induced red blood cell aplasia in a patient with hereditary pyropoikilocytosis (Letter). Blood 1995;86:411-412.
42. Duncan JR, Potter CB, Cappellini MD et al. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet 1983:ii:14-16.
43. Rechavi G, Vonsover A, Manor Y et al. Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5′-nucleoudase deficiency. Acta Haematol 1989;82:46-49.
44. Smith MA, Shah NS, Lobel JS. Parvovirus B19 infection associated with reticulocytopenia and chronic autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1989:11.167-169.
45. Frickhofen N, Raghavachar A, Heit W et al. Human parvovirus infection (Letter). N Engl J Med 1986.314:646.
46. Lefrere JJ, Bourgeois H. Human parvovirus associated with erythroblastopenia in iron deficiency anaemia (Letter). J Clin Pathol 1986;39:1277-1278.
47. Neild G, Anderson M, Hawes S et al. Parvovirus infection after renal transplant (Letter). Lancet 1986:ii:1226-1227.
48. Niitsu H, Takatsu H. Miura I et al. Pure red cell aplasia induced by B 19 parvovirus during allogeneic bone marrow transplantation. Rinsho Ketsueki 1990;31:1566-1571.
49. Hamon MD. Newland AC. Anderson MJ. Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia (Letter). J Clin Pathol 1988;41:1242.
50. Guillot M, Lefrere JJ, Ravenet N et al. Acute anaemia and aplastic crisis without haemolysis in human parvovirus infection (Letter). J Clin Pathol 1987;40:1264-1265.
51. Conrad ME, Studdard H, Anderson LJ. Aplastic crisis in sickle cell disorders: bone marrow necrosis and human parvovirus infection. Am J Med Sci 1988;295:212-215.
52. Godeau B, Galacteros F, Schaeffer A et al. Aplastic crisis due to extensive bone marrow necrosis and human parvovirus infection in sickle cell disease (Letter). Am J Med 1991;91:557-558.
53. Serjeant GR. Sickle Cell Disease. 2nd ed. Oxford: Oxford University Press. 1992:95.
54. McLellan NJ, Rutter N. Hereditary spherocytosis in sisters unmasked by parvovirus infection. Postgrad Med J 1987;63:49-50.
55. Cutlip AC, Gross KM, Lewis MJ. Occult hereditary spherocytosis and human parvovirus infection. J Am Board Fam Pract 1991;4:461-464.
56. Anderson MJ, Davis LR. Hodgson J et al. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol 1982;35:744-749.
57. Young NS, Mortimer PP. Moore JG et al. Characterization of a virus that causes transient aplastic crisis J Clin Invest 1984;73:224-230.
58. Bhambhani K, Inoue S, Sarnaik SA et al. Transient erythroblastopenia of childhood not associated with human parvovirus infection (Letter). Lancet 1986;i:509.
59. Hanada T, Koike K. Hirano C et al. Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Eur J Haematol 1989;42:77-80.
60. Wodzinski MA, Lilleyman JS. Transient erythroblastopenia of childhood due to human parvovirus B19 infection. Br J Haematol 1989;73:127-128.
61. Nagai K, Morohoshi T, Kudoh T et al. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol 1992;80:131-132.
62. Saunders PW, Reid MM, Cohen BJ. Human parvovirus induced cytopenias: a report of five cases (Letter), Br J Haematol 1986;63:407-410.
63. Doran HM, Teall AJ. Neutropenia accompanying erythroid aplasia in human parvovirus infection. Br J Haematol 1988;69:287-288.
64. Inoue S, Kinra NK, Mukkamala SR et al. Parvovirus B-19 infection: aplastic crisis, erythema infectiosum and idiopathic thrombocytopenic purpura. Pediatr Infect Dis J 1991;10:251-253.
65. Foreman NK, Oakhill A, Caul EO. Parvovirus-associated thrombocytopenic purpura (Letter). Lancet 1988:ii:1426-1427.
66. Lefrère JJ, Couroucé AM, Muller JY et al. Human parvovirus and purpura (Letter). Lancet 1985;ii:730.
67. Lefrère JJ, Couroucé AM, Kaplan C. Parvovirus and idiopathic thrombocytopenic purpura (Letter). Lancet 1989:i:279.
68. Hanada T, Koike K, Takeya T et al. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol 1988;70:113-115.
69. McClain K, Estrov Z. Chen H et al. Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies. Br J Haematol 1993;85:57-62.
70. Hartman KR, Brown KE, Green SW et al. Lack of evidence for parvovirus B19 viraemia in children with chronic neutropenia (Letter). Br J Haematol 1994;84:895-896.
71. Pont J. Puchhammer-Stockl E, Chott A et al. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol 1992;80:160-165.
72. Kurtzman GJ, Ozawa K, Cohen B et al. Chronic bone marrow failure due to persistent B 19 parvovirus infection. N Engl J Med 1987;317:287-294.
73. Davidson JE, Gibson B, Gibson A et al. Parvovirus infection, leukaemia, and immunodeficiency (Letter). Lancet 1989;i:102.
74. Gahr M, Pekrun A, Eiffert H. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Pediatr 1991;150:470-472.
75. Kurtzman G, Frickhofen N. Kimball J et al. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy (Comments). N Engl J Med 1989;321:519-523.
76. Frickhofen N, Abkowitz JL. Safford M et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-933.
77. Anderson MJ, Kidd IM, Jones SE et al. Parvovirus infection and the acquired immunodeficiency syndrome (Letter). Ann Intern Med 1985;102:275.
78. Abkowitz JL. Brown KE, Wood RW et al. Human parvovirus B19 (HPV B19) is not a rare cause of anemia in HIV-seropositive individuals. Clin Res 1993;41:393a.
79. Kurtzman GJ, Cohen B. Meyers P et al. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 1988;ii:1159-1162.
80. Smith MA, Shah NR, Lobel JS et al. Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy. Clin Pediatr (Phila) 1988;27:383-386.
81. Carstensen H, Ornvold K, Cohen BJ. Human parvovirus B19 infection associated with prolonged erythroblastopenia in a leukemic child. Pediatr Infect Dis J 1989;8:56.
82. Weiland HT, Salimans MM. Fibbe WE et al. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient (Letter). Br J Haematol 1989,71:300.
83. Risdall RJ, McKenna RW. Nesbit ME et al. Virus-associated hemophagocytic syndrome. Cancer 1979;44:993-1002.
84. Reiner AP, Spivak JL. Hematophagic histiocytosis: a report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988;67:369-388.
85. Hanada T, Yamamura H, Isobe T et al. Pure red cell aplasia in association with malignant histiocytosis. Cancer 1986;57:2325-2328.
86. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989;73:2128-2132.
87. Koch WC, Massey G, Russell CE et al. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr 1990;116:355-359.
88. Boruchoff SE, Woda BA, Pihan GA et al. Parvovirus B19-associated hemophagocytic syndrome. Arch Intern Med 1990;150:897-899.
89. Muir K, Todd WT, Watson WH et al. Viral-associated haemophagocytosis with parvovirus-B 19-related pancytopenia. Lancet 1992;339:1139-1140.
90. Renter JI, Ehrnst A, Andersson J et al. Familial hemophagocytic lymphohistiocytosis and viral Infections. Acta Paediatr 1993;82:369-372.
91. Uike N, Miyamura T. Obama K et al. Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia. Br J Haematol 1993;84:530-532.
92. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol 1995;89:923-926.
93. Brown KE, Green SW. Antunez de Mayolo J et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994;343:895-896.
94. Patou G, Pillay D, Myint S et al. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol 1993;31:540-546.
95. Gallinella G, Anderson SM, Young NS et al. Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture, J Virol 1995;69:3897-3899.